A comment on 'the risk of coronary heart disease in type 2 diabetic patients exposed to thiazolidinediones compared to metformin and sulfonylurea therapy'

Pharmacoepidemiol Drug Saf. 2007 Oct;16(10):1072-3; author reply 1073-4. doi: 10.1002/pds.1465.
No abstract available

Publication types

  • Comment
  • Comparative Study
  • Letter

MeSH terms

  • Coronary Disease / chemically induced*
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Drug Therapy, Combination
  • Humans
  • Hypoglycemic Agents / adverse effects*
  • Metformin / adverse effects*
  • Sulfonylurea Compounds / adverse effects*
  • Thiazolidinediones / adverse effects*

Substances

  • Hypoglycemic Agents
  • Sulfonylurea Compounds
  • Thiazolidinediones
  • Metformin